Does MEDVi Accept Insurance? The Verified 2026 Answer (Cash-Pay, HSA/FSA, and Reimbursement Explained)
Weight Loss Provider Guide Editorial Team ·
This page contains affiliate links — we may earn a commission if you sign up through them, at no additional cost to you. This does not influence our verification process or the recommendations below.
This page covers payment and provider-selection information, not medical advice. A licensed clinician determines whether GLP-1 treatment is appropriate for your situation.
No, MEDVi does not accept insurance.
All MEDVi prescriptions — both compounded and brand-name — are cash-pay, and MEDVi’s affiliated medical professional entities are out-of-network with commercial and government health insurance plans, including Medicare and Medicaid (per MEDVi’s own terms of service).
HSA and FSA are advertised as accepted at MEDVi, and prescription medical care for a diagnosed condition like obesity may qualify as an HSA/FSA-eligible expense — but final eligibility depends on your plan administrator. Don’t assume; verify.
Here’s what most pages skip: “MEDVi doesn’t take insurance” doesn’t automatically mean you should walk away. Coverage for weight-loss GLP-1s remains limited — in 2025, only 19% of firms with 200+ workers and 43% of firms with 5,000+ workers covered GLP-1s for weight loss in their largest plan (KFF/Peterson Health System Tracker). For people whose insurance excludes weight-loss meds outright, paying MEDVi cash with HSA/FSA dollars often beats fighting a prior authorization that’s unlikely to succeed.
Quick Verdict: What Should YOU Do Right Now?
| Your situation | Best path | Real monthly cost |
|---|---|---|
| Uninsured, or your plan excludes weight-loss meds | MEDVi (compounded) | $179 first month, $299 ongoing |
| You have HSA/FSA dollars to spend | MEDVi + HSA/FSA | ~$194–$263/month effective (federal tax savings only) |
| Your plan covers Wegovy/Zepbound | Ro's insurance concierge | $39 first month, then as low as $74/month + medication |
| You only want FDA-approved brand-name meds at lowest cash price | Ro (matches NovoCare and LillyDirect rates) | $39 first month, then $149/month + medication |
| You're on Medicare or Medicaid | Your PCP + plan-specific path (not MEDVi) | Varies — see Medicare section below |
| Honestly not sure | Take our 60-second matching quiz | Free |
What We Actually Verified Before Publishing This Page
We didn’t read three review sites and call it a day. Before publishing, we cross-checked MEDVi’s own legal documents against current pricing, IRS guidance, FDA enforcement records, CMS announcements, and the alternatives we recommend. Here’s the dated evidence trail.
| Claim category | Source checked | Verified value | Date verified |
|---|---|---|---|
| MEDVi cash-pay model | glp.medvi.org and home.medvi.org/terms-and-conditions | "All MEDVi prescriptions are cash-pay"; affiliated providers "are not contracted healthcare providers with any health insurance plans" | April 28, 2026 |
| MEDVi semaglutide injection price | glp.medvi.org | $179 first month / $299 refills | April 28, 2026 |
| MEDVi semaglutide tablets | glp.medvi.org | "Starting at $249" first month | April 28, 2026 |
| MEDVi tirzepatide / brand-name prices | glp.medvi.org product cards | "$99 Membership + Medication Cost"; specific tirzepatide and brand cash prices require checkout verification | April 28, 2026 |
| MEDVi cancellation policy | home.medvi.org/cancellation-and-refund-policy | Cancellation must be requested at least 72 hours before next billing date | April 28, 2026 |
| MEDVi FDA warning letter | fda.gov inspection records | Warning letter issued February 20, 2026 regarding compounded semaglutide and tirzepatide marketing claims | April 28, 2026 |
| HSA/FSA medical expense rules | irs.gov FAQ on medical expenses | Medical care for diagnosis, cure, mitigation, treatment, or prevention of disease may qualify; weight loss for general health does not | April 28, 2026 |
| Ro pricing | ro.co/weight-loss/pricing | $39 first month, $149/month ongoing, as low as $74/month with annual prepay | April 28, 2026 |
| NovoCare Wegovy pricing | novocare.com | $199/month for 0.25 mg and 0.5 mg new patients (first 2 fills); then $349/month standard; $399/month for HD 7.2 mg | April 28, 2026 |
| LillyDirect Zepbound pricing | investor.lilly.com / lillydirect.lilly.com | $299/month for 2.5 mg, $399/month for 5 mg, $449/month for other approved doses (Self Pay Journey) | April 28, 2026 |
| Medicare GLP-1 Bridge | cms.gov | Begins July 1, 2026, extended through Dec 31, 2027; $50 pharmacy copay; no paper claims; not available through MEDVi | April 28, 2026 |
| Commercial employer GLP-1 coverage | KFF / Peterson Health System Tracker | 19% of firms with 200+ workers and 43% of firms with 5,000+ workers covered GLP-1s for weight loss in 2025 | April 28, 2026 |
| MEDVi Trustpilot snapshot | trustpilot.com/review/medvi.org | 4.4 numeric score, 4.5 TrustScore, 12,583 total reviews; 78% 5-star, 11% 1-star | April 28, 2026 |
Does MEDVi Accept Insurance? MEDVi’s Policy Line by Line
Answer capsule: MEDVi operates on a 100% cash-pay model. According to MEDVi’s terms of service, its affiliated medical professional entities are not contracted healthcare providers with any health insurance plans, commercial or government, including Medicare and Medicaid. The company does not file insurance claims on patients’ behalf. HSA and FSA are advertised as accepted, and patients may independently submit brand-name medication receipts to their insurer for possible reimbursement, but don’t budget around it.
If you remember nothing else from this page, remember this table.
| Payment / coverage type | Accepted? | Plain English |
|---|---|---|
| Commercial insurance billing (in-network) | ❌ No | MEDVi's affiliated providers have no insurance contracts. Don't expect them to bill Aetna, BCBS, Cigna, UnitedHealthcare, Kaiser, or anyone else. |
| MEDVi files a claim on your behalf | ❌ No | You pay MEDVi. MEDVi does not submit claims to your insurer. |
| Self-submitted reimbursement (compounded medications) | ⚠️ Don't budget around it | Compounded GLP-1s aren't on commercial formularies; reimbursement realistically rare. |
| Self-submitted reimbursement (brand-name Wegovy / Ozempic / Zepbound via MEDVi) | ⚠️ Possible, not guaranteed | Some patients with out-of-network prescription benefits may submit for partial reimbursement, but verify before assuming. |
| HSA card at checkout | ✅ Advertised as accepted | MEDVi displays "HSA/FSA Approved." Final eligibility depends on your plan administrator. |
| FSA card at checkout | ✅ Advertised as accepted | Same as above. Some FSAs require a Letter of Medical Necessity for weight-loss-related expenses. |
| Medicare (Original / Part D / Advantage) | ❌ No | Per MEDVi's terms, affiliated providers are out-of-network with government plans including Medicare. |
| Medicaid | ❌ No | Per MEDVi's terms, out-of-network with government plans including Medicaid. |
| Manufacturer copay/savings cards (Wegovy, Zepbound) | ⚠️ Verify before assuming | These cards have specific terms tied to insurance type and dispensing pharmacy. Don't assume they apply to MEDVi's cash-pay route. |
| Care Credit / BNPL (Affirm, Klarna, Afterpay) | ⚠️ Verify at checkout | MEDVi doesn't publicly advertise BNPL as a primary payment method. Confirm at checkout. |
Why Doesn’t MEDVi Take Insurance? (And Why That’s Actually a Feature, Not a Bug)
Answer capsule: MEDVi’s public model is cash-pay. That structure removes the insurance billing infrastructure baked into brand-name prescription pricing — which is part of why MEDVi’s compounded semaglutide injection costs $299/month versus Wegovy’s $1,349.02 list price.
Insurance billing isn’t free. For a provider to bill your insurance directly, they need negotiated network contracts, a credentialed provider directory, a prior-authorization team, claims-processing software, denial-appeals staff, and a formulary that includes whatever they’re prescribing. Every one of those costs gets baked into the list price of an in-network prescription.
MEDVi prescribes compounded medications — semaglutide and tirzepatide formulations made by state-licensed compounding pharmacies (MEDVi currently lists partner pharmacies including Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding). Those products aren’t FDA-approved finished products and aren’t on insurer formularies, so there’s nothing to authorize, nothing to deny, and no billing stack needed.
The trade-off that gets you to $179 first month / $299 ongoing:
A fraction of brand-name retail pricing. No prior authorization. No “your plan denied this medication” letter six weeks after your appointment.
One honest admission, then the pivot
MEDVi does NOT make insurance easier — and if your priority is getting your insurance company to pay for a brand-name GLP-1, MEDVi is not the right first stop. Ro’s insurance concierge handles paperwork, coordination, and prior-authorization submissions, and Ro’s medication pricing matches NovoCare and LillyDirect direct-to-patient rates.
Can I Use HSA or FSA on MEDVi? (Yes — Here’s the Math)
Answer capsule: MEDVi advertises HSA/FSA as accepted at checkout. Under IRS guidance, prescription medical care for the diagnosis, treatment, or prevention of a specific disease — including obesity — may qualify as a reimbursable medical expense. Final eligibility, card acceptance, and documentation requirements depend on your specific plan administrator.
Why GLP-1s may qualify under IRS rules
The IRS treats medical care expenses as eligible when they are for the diagnosis, cure, mitigation, treatment, or prevention of disease — not for general health, wellness, or appearance. A clinician-diagnosed obesity (BMI ≥30) or overweight-with-comorbidity (BMI ≥27 + hypertension, diabetes, sleep apnea, or dyslipidemia) prescription is a recognized medical-treatment context. The question that determines whether your charge gets reimbursed isn’t “is the medication FDA-approved” — it’s “does my administrator accept the documentation I provide for this expense.”
When you might need a Letter of Medical Necessity (LMN)
Some FSA administrators (and a smaller number of HSA administrators) require a Letter of Medical Necessity to release reimbursement for weight-loss-related expenses. Before you sign up, ask MEDVi support directly whether they can provide a Letter of Medical Necessity, an itemized receipt with diagnosis information, and your prescriber’s NPI. Get the answer in writing through the patient portal.
Real-dollar HSA/FSA savings on MEDVi (steady-state refill year, federal tax savings only)
Math based on MEDVi’s published $299/month semaglutide injection refill × 12 = $3,588 ongoing annual cost. Federal income tax only — actual savings increase with state income tax.
| Marginal federal tax bracket | Approximate annual savings on $3,588/yr | Effective monthly cost |
|---|---|---|
| 12% | ~$430/year saved | ~$263/month |
| 22% | ~$789/year saved | ~$233/month |
| 24% | ~$861/year saved | ~$227/month |
| 32% | ~$1,148/year saved | ~$204/month |
| 35% | ~$1,256/year saved | ~$194/month |
For a 24%-bracket household paying state income tax, MEDVi’s effective cost can land closer to ~$210/month. That’s not insurance “covering” the medication — but it’s real money that most MEDVi customers leave on the table.
Card-at-checkout vs. pay-and-reimburse: which is cleaner?
Card at checkout
- ✓ Faster — no out-of-pocket cash flow
- ⚠ Some plans flag charges and request itemized receipts after the fact. Have your MEDVi receipt saved.
Pay with credit card and submit for reimbursement
- ✓ Cleaner audit trail
- ✓ Earns credit card rewards (the underrated win)
- ⚠ Slower payback — usually 7–30 days
What to do if your administrator denies the claim
Will My Insurance Reimburse Me for MEDVi? (The Honest Answer)
Answer capsule: Don’t budget around it. Compounded GLP-1 products are not FDA-approved finished products and don’t process through commercial formularies. For MEDVi’s brand-name Wegovy or Ozempic prescriptions, some patients with out-of-network prescription benefits have submitted for partial reimbursement, but going through Ro’s insurance concierge or your PCP typically beats this approach financially.
For compounded GLP-1 medications (the $179/$299 path)
Realistically, no. Compounded GLP-1 products are not FDA-approved finished products. They aren’t on commercial formularies, so insurers generally treat them as non-covered. Plan as if you’ll see zero reimbursement on the compounded side — ask your insurer to confirm before assuming otherwise.
For MEDVi’s brand-name Wegovy or Ozempic prescriptions
Possible but rarely the smartest financial move. If your plan covers the brand-name drug, the in-network path is significantly cheaper: the Wegovy Savings Card lets eligible commercially insured patients pay as little as $25/month if their plan covers Wegovy. The math is brutal — if your insurance covers the brand-name drug, the in-network path saves you hundreds of dollars per month over MEDVi cash + reimbursement.
What MEDVi may or may not provide for an insurance claim
This is the table competitor pages get wrong. Ask MEDVi support directly before you pay, and get the answer in writing through the patient portal.
| Document | Status | What to do |
|---|---|---|
| Itemized receipt | Generally available | Confirm format with MEDVi support |
| Diagnosis information | Generally available in patient records | Ask whether ICD-10 codes are included on the receipt |
| Prescriber NPI | Verify with support | Required by some insurers and HSA/FSA administrators |
| Letter of Medical Necessity | Verify with support | Some FSAs require this; ask before assuming MEDVi provides it |
| Formal CPT/HCPCS-coded superbill | Verify — likely not standard | MEDVi's cash-pay model isn't built around superbills; ask if you need one |
| NDC for compounded products | Not applicable | Compounded medications aren't FDA-approved finished products and don't process like formulary drugs |
4-question script to call your insurer before paying MEDVi cash
- 1. "Do I have out-of-network prescription benefits on my plan, and what’s the reimbursement percentage after my deductible?"
- 2. "Is [Wegovy/Ozempic/Zepbound] covered on my plan’s formulary, and does it require prior authorization?"
- 3. "If I pay cash for [Wegovy/Ozempic/Zepbound] from an out-of-network provider, what documentation do I need — itemized receipt, prescription, diagnosis code, prescriber NPI, Letter of Medical Necessity?"
- 4. "What’s the reimbursement timeline, and is partial reimbursement common for brand-name weight-loss medications obtained out-of-network?"
If they tell you reimbursement is “case-by-case” or “depends on plan terms,” that’s plan-language for don’t budget around it.
Honestly? If your plan covers Wegovy or Zepbound, paying MEDVi cash for the brand-name route to self-submit for reimbursement is almost never the right move financially. The Wegovy Savings Card and Zepbound Savings Card can drop eligible commercially insured patients’ cost to as little as $25, and Ro’s insurance concierge does the prior-authorization work for you.
→ My plan might cover Wegovy or Zepbound — Check Ro's free Coverage CheckerDoes MEDVi Accept Medicare or Medicaid?
Answer capsule: No. Per MEDVi’s terms, affiliated medical professional entities are out-of-network with all government health insurance plans, including Medicare and Medicaid. Medicare beneficiaries generally have no out-of-network reimbursement pathway for outpatient prescriptions, so paying MEDVi cash and submitting a Medicare claim won’t work. Do not expect Medicare, Medicaid, or the Medicare GLP-1 Bridge to reimburse a MEDVi cash transaction.
The Medicare paths that DO exist (not through MEDVi)
Medicare Part D may cover Wegovy for cardiovascular event risk reduction
Following the FDA’s expanded indication, Medicare Part D plans can cover Wegovy when prescribed for reducing major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight — not for weight loss alone. This requires a Part D plan that includes Wegovy on its formulary plus prior authorization.
Medicare Part D may cover Zepbound for moderate-to-severe sleep apnea in adults with obesity
Zepbound has an FDA-approved indication for moderate-to-severe OSA in adults with obesity, and Part D coverage exists when criteria are met.
Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027)
| Medicare GLP-1 Bridge fact | Verified detail |
|---|---|
| Start date | July 1, 2026 |
| End date | December 31, 2027 |
| Eligible products | Foundayo, Wegovy injection, Wegovy tablets, Zepbound KwikPen |
| Pharmacy copay | $50 |
| Claims mechanism | Central processor; no paper claims and no direct member reimbursement accepted |
| Available through MEDVi? | No — MEDVi is not contracted with the Bridge |
Medicaid is a state-by-state situation
KFF reported that 13 state Medicaid programs covered GLP-1s for obesity treatment under fee-for-service as of January 2026, typically with prior authorization. Coverage can change mid-year. The only reliable answer is to call your specific state Medicaid plan and ask.
How Much Does MEDVi Actually Cost Without Insurance?
Answer capsule: MEDVi’s compounded semaglutide injections are publicly verified at $179 for the first month and $299 for monthly refills, putting first-year cost at $3,468. MEDVi advertises GLP-1 tablets starting at $249 first month, and brand-name routes are displayed as “$99 Membership + Medication Cost.” Exact tirzepatide and brand-name medication cash prices need checkout or support verification before relying on them.
Verified directly from MEDVi’s public page
| Medication route | Month 1 | Refill price | First-year math |
|---|---|---|---|
| Compounded semaglutide injection | $179 | $299 | $179 + ($299 × 11) = $3,468 |
| Compounded semaglutide tablets | "Starting at $249" | Confirm at checkout | Confirm at checkout |
Needs checkout or support verification before relying on
| Medication route | What MEDVi shows | What to do |
|---|---|---|
| Compounded tirzepatide injection | Listed as a product; refill price not on public page | Screenshot at checkout |
| Compounded tirzepatide tablets | Listed as a product; refill price not on public page | Screenshot at checkout |
| Wegovy pill | "$99 Membership + Medication Cost" | Get exact medication cash price at checkout |
| Wegovy injection | "$99 Membership + Medication Cost" | Get exact medication cash price at checkout |
| Zepbound injection | "$99 Membership + Medication Cost" | Get exact medication cash price at checkout |
| Ozempic injection | Listed in older MEDVi materials around $1,999/month — verify at checkout | Confirm before paying; product mix in MEDVi web properties is in transition |
How that compares to manufacturer and Ro paths (verified April 2026)
| Path | Verified pricing |
|---|---|
| MEDVi compounded semaglutide injection | $179 first month, $299/month refills = $3,468 first year |
| MEDVi compounded semaglutide injection + HSA/FSA (24% bracket) | ~$220/month effective first year |
| Ro membership | $39 first month, $149/month ongoing, or as low as $74/month with annual prepay |
| Ro + Wegovy with insurance + Wegovy Savings Card (eligible patients) | Membership + as little as $25/month for medication |
| NovoCare Wegovy (cash-pay, new patients) | $199/month for 0.25/0.5 mg through June 30, 2026; then $349/month standard; $399/month Wegovy HD 7.2 mg |
| LillyDirect Zepbound vials (Self Pay Journey Program) | $299/month for 2.5 mg, $399/month for 5 mg, $449/month for other approved doses |
| Wegovy retail without insurance or savings card | ~$1,349/month list price |
When MEDVi Still Wins — And When It Doesn’t
✅ MEDVi is the right call if you’re:
- ✓Uninsured: No insurance to coordinate, predictable bundled monthly price.
- ✓Insured but your plan excludes weight-loss medications: Fighting an exclusion takes months and usually loses. MEDVi works around it.
- ✓HSA or FSA spender: Pre-tax dollars stretch the $299 effectively to ~$194–$263, depending on bracket.
- ✓Frustrated with prior authorization: Your time has value. So does avoiding a 6–10 week PA gauntlet that might end in denial.
- ✓Needle-averse and want the daily oral tablet option: MEDVi offers compounded oral semaglutide tablets and oral tirzepatide tablets.
- ✓Looking for predictable, bundled pricing on the semaglutide injection program: The published price is the price (final charges may fluctuate per MEDVi terms).
❌ MEDVi is the wrong call — go elsewhere — if you’re:
- ✕Insured with strong Wegovy/Zepbound coverage: Your plan + Savings Card can get eligible patients to as little as $25/month. → Use Ro.
- ✕On Medicare or Medicaid: MEDVi won't bill you any other way than out-of-pocket, and your plan won't reimburse. → Talk to your PCP.
- ✕Specifically committed to FDA-approved finished products only: → Use Ro for brand-name at NovoCare/LillyDirect-matched cash-pay rates.
- ✕Worried about cancellation friction: MEDVi requires cancellation at least 72 hours before your next billing date; some patients report needing multiple contacts.
- ✕Concerned about FDA regulatory standing: FDA issued MEDVi a February 20, 2026 warning letter regarding marketing claims about compounded semaglutide and tirzepatide products.
The honest pivot table for the wrong-fit reader
| If you fall into this group | Best alternative |
|---|---|
| Insurance covers Wegovy/Zepbound | Ro's coverage checker and insurance concierge |
| Want FDA-approved brand at lowest cash price | Ro (matches NovoCare/LillyDirect) |
| Want broadest brand-name comparison shopping | Sesame Care |
| Medicare or Medicaid | Your PCP / endocrinologist + plan-specific pathway |
| Just exploring and unsure | Take our 60-second matching quiz |
What to Verify Before You Pay MEDVi (Cash-Pay Smart-Buyer Checklist)
When insurance is in the loop, your insurer is a second set of eyes on every charge. When you’re cash-pay, you’re the only set of eyes. Here’s the pre-checkout verification routine we’d run if we were paying $3,468 of our own money.
Screenshot these before clicking pay
Eight questions to ask MEDVi support before paying
Send these as a single message in the patient portal. Save the response.
- 1. "Can you confirm in writing my refill price after the introductory month?"
- 2. "Will my prescription be filled with a compounded medication or a brand-name FDA-approved medication?"
- 3. "Which pharmacy will dispense my prescription, and is it state-licensed where I live?"
- 4. "Can I receive an itemized receipt suitable for HSA/FSA reimbursement, including diagnosis information?"
- 5. "Can you provide a Letter of Medical Necessity if my HSA/FSA administrator requests one?"
- 6. "Can you provide your prescriber's NPI on the receipt?"
- 7. "What is the deadline to cancel before the next charge — and what's the exact process?"
- 8. "What happens if my clinician later determines I'm not eligible to continue — am I refunded for unused medication?"
Verify the pharmacy
MEDVi currently lists partner pharmacies including Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding (confirm with MEDVi which specific pharmacy will dispense your prescription). Look up that pharmacy on the NABP “Verify Before You Buy” tool or your state pharmacy board’s licensing database. This is a 5-minute exercise — we strongly recommend it for any cash-pay compounded GLP-1 path, not just MEDVi.
Is MEDVi Legit If It Doesn’t Take Insurance?
Answer capsule: Cash-pay status alone doesn’t determine legitimacy. MEDVi holds a 4.4–4.5 Trustpilot score across 12,583 reviews as of April 28, 2026, and received an FDA warning letter dated February 20, 2026 regarding marketing claims about its compounded products.
What the review pattern actually shows
| Signal | Verified value (April 28, 2026) |
|---|---|
| Numeric score | 4.4 |
| TrustScore graphic | 4.5 stars |
| Total reviews | 12,583 |
| 5-star | 78% |
| 4-star | 6% |
| 3-star | 3% |
| 2-star | 2% |
| 1-star | 11% |
Trustpilot does not fact-check review claims. Recent positive reviews emphasize fast onboarding and responsive support. Recent negative reviews include allegations of shipping, billing, and cancellation friction.
The FDA warning letter
On February 20, 2026, the FDA issued MEDVi, LLC a warning letter regarding website content that included false or misleading claims about its compounded semaglutide and tirzepatide products. The letter addressed marketing language and required corrective action — it did not involve product seizures, safety recalls, or injunctions. We’re surfacing this because a reasonable reader would want to know before paying. MEDVi continues to operate, holds LegitScript certification, and discloses that its compounded GLP-1s are not FDA-approved on its own materials.
Our read: this is a marketing-claims regulatory action, not a product safety action. It’s a reason to verify exactly what medication you’re prescribed, which pharmacy fills it, and what the receipt says before you pay.
Three real customer voices from MEDVi’s published testimonials
"MEDVi Doctors & Staff have been very professional and prompt with any questions I have and their support & care. I feel in great hands! I'm 13 lbs away from goal."
— Patient testimonial published on MEDVi.org
"My Clinician was kind, informative, gave a clear understanding of expectations, what was needed and future follow-ups and dosage changes."
— Patient testimonial published on MEDVi.org
"If I call, I get an immediate answer from a real person."
— Patient testimonial published on MEDVi.org
Read these as support signals, not weight-loss results promises. Individual results from any GLP-1 program vary based on dosing, adherence, diet, exercise, starting weight, and underlying medical factors. Results are individual and not typical.
→ The trade-offs are clear and the price fits — Check MEDVi pricingThe MEDVi Insurance Decision Tree
Five yes/no questions. If you skipped to the bottom or got overwhelmed by the math, this section is for you.
START → "Do you have health insurance?"
├─ NO → Go to Q2
└─ YES → Go to Q2
Q2: "Does your plan currently cover any GLP-1 weight-loss medication?"
├─ NO or NOT SURE → Go to Q3
└─ YES → ★ Use Ro's insurance concierge — handles prior auth
and coverage paperwork. Don't pay MEDVi $299/mo
for compounded if your plan covers brand-name
you can get for as little as $25/mo with a
manufacturer savings card.
Q3: "Do you have an HSA or FSA you can spend?"
├─ NO → Go to Q4
└─ YES → ★ MEDVi + HSA/FSA may be your path.
Effective cost ~$194–$263/mo at federal brackets.
Q4: "Are you on Medicare, Medicaid, TRICARE, or VA?"
├─ YES → ✗ MEDVi can't help. Talk to your PCP about
cardiovascular or OSA Medicare pathways.
Mark July 2026 for the Medicare GLP-1 Bridge.
└─ NO → Go to Q5
Q5: "Do you specifically want FDA-approved brand-name only?"
├─ YES → ★ Use Ro for brand-name at NovoCare/LillyDirect rates.
└─ NO → ★ MEDVi compounded semaglutide injection is your path.
$179 first month, $299 ongoing.MEDVi Insurance FAQ
Does MEDVi accept insurance?
No. MEDVi is a 100% cash-pay GLP-1 telehealth platform. Per MEDVi's terms of service, its affiliated medical professional entities are not contracted with any health insurance plans, commercial or government. The company does not file insurance claims on patients' behalf.
Does MEDVi take Blue Cross, Aetna, Cigna, UnitedHealthcare, or Kaiser?
No. MEDVi's affiliated providers are out-of-network with all commercial insurance plans. Treat MEDVi as cash-pay regardless of your specific commercial carrier. Plan-specific reimbursement of brand-name medication receipts is theoretically separate from MEDVi billing insurance directly, but reimbursement is not guaranteed and should be verified with your insurer before paying.
Does MEDVi accept HSA?
MEDVi advertises HSA/FSA as accepted at checkout. Prescription medical care for a diagnosed condition like obesity may qualify as an HSA-eligible expense under IRS rules. Save your itemized receipt and confirm eligibility with your plan administrator.
Does MEDVi accept FSA?
Same answer as HSA. MEDVi advertises FSA acceptance at checkout. Some FSA administrators require a Letter of Medical Necessity for weight-loss-related expenses; ask MEDVi support whether they can provide one.
Does MEDVi accept Medicare?
No. Per MEDVi's terms, affiliated providers are out-of-network with all government health plans, including Original Medicare, Medicare Advantage, and Medicare Part D. Medicare also generally has no out-of-network reimbursement pathway for outpatient prescriptions. Do not expect Medicare or the upcoming Medicare GLP-1 Bridge to reimburse a MEDVi cash transaction.
Does MEDVi accept Medicaid?
No. MEDVi is out-of-network with Medicaid in all states and does not bill state Medicaid programs. Medicaid GLP-1 coverage for obesity remains limited — KFF reported 13 state Medicaid programs covered GLP-1s for obesity treatment under fee-for-service as of January 2026.
Will my insurance reimburse me for MEDVi?
Don't budget around it. Compounded GLP-1 products are not FDA-approved finished products and aren't on commercial formularies, so reimbursement is rare. For MEDVi's brand-name medication routes, reimbursement is theoretically possible if you have out-of-network prescription benefits, but going through Ro's insurance concierge or your PCP is usually meaningfully cheaper.
Does MEDVi give a superbill?
Verify with MEDVi support before paying. MEDVi's cash-pay model isn't built around formal CPT/HCPCS-coded superbills, but itemized receipts and Letters of Medical Necessity may be available on request. For HSA/FSA reimbursement, an itemized receipt is typically sufficient.
Why is MEDVi cheaper without insurance than Wegovy with insurance can be?
MEDVi's $299/month semaglutide injection refill covers a compounded medication, the prescribing clinician, support, and shipping in one cash price. Brand-name Wegovy carries a list price of about $1,349/month before insurance discounts. Compounded medications skip the FDA finished-product review process and the insurance billing infrastructure that's baked into brand-name pricing.
What if my insurance covers Wegovy?
Use it. Going through Ro's insurance concierge or your primary care physician, combined with the Wegovy Savings Card, can reduce eligible commercially insured patients' out-of-pocket cost to as little as $25/month for the medication itself — far less than MEDVi's compounded cash pricing.
Can I switch from MEDVi to a brand-name medication later if my insurance starts covering it?
Yes. MEDVi has no long-term contract and bills on a 28-day cycle. As long as you cancel at least 72 hours before your next billing date, you can move to a brand-name path through your PCP, Ro, or another provider whenever your coverage situation changes.
Does MEDVi help with prior authorization?
No. MEDVi's cash-pay model means there's no insurance billing process to authorize. If prior authorization is your main obstacle, Ro's insurance concierge handles coverage coordination and prior-authorization submissions.
Is "no insurance required" the same as "insurance accepted"?
"No insurance required" means you can use the service without having insurance — typically because the provider is cash-pay only. "Insurance accepted" would mean the provider bills your health plan directly. MEDVi falls into the first category, not the second.
Are MEDVi's compounded medications FDA-approved?
No. Compounded medications are made by state-licensed compounding pharmacies but are not reviewed by the FDA as finished products for safety, effectiveness, and quality. This is true of all compounded GLP-1 telehealth providers, not specific to MEDVi. If FDA-approved finished products are your priority, choose a brand-name path through Ro or your PCP.
Bottom Line
If your insurance excludes weight-loss medications anyway
MEDVi’s cash-pay model isn’t a downside — it’s the workaround. The $179 first month and $299 ongoing pricing on the semaglutide injection program is one of the most predictable, lowest-friction cash paths to GLP-1 treatment that exists, and HSA/FSA dollars stretch it further.
If your insurance does cover Wegovy or Zepbound
Ro is the right answer. Their insurance concierge handles coverage coordination, their cash-pay pricing matches NovoCare and LillyDirect direct-to-patient rates, and the Wegovy or Zepbound Savings Card can get eligible commercially insured patients to as little as $25/month medication cost.
If you’re on Medicare or Medicaid
Neither cash-pay telehealth platform is your path right now. Talk to your PCP about the Medicare cardiovascular or obstructive sleep apnea indications today, and watch CMS for the GLP-1 Bridge launching July 1, 2026. See our full Medicare GLP-1 payment guide.
→ Cash-pay or HSA/FSA fits you?
The semaglutide injection program is currently $179 first month / $299 ongoing — bundled price covers your medication, prescribing clinician, support, and shipping. No insurance paperwork, no prior authorization wait. HSA/FSA advertised as accepted at checkout. Final charges may fluctuate per MEDVi’s terms based on prescribed medication and pharmacy.
Check MEDVi pricing and eligibility →→ Want your insurance checked first?
Free coverage report using your insurance card information for GLP-1 medications such as Ozempic, Wegovy, and Zepbound. If your plan covers a brand-name GLP-1, Ro’s insurance concierge handles coverage paperwork and prior-authorization submissions. Ro membership: $39 first month, $149/month ongoing, or as low as $74/month with annual plan paid upfront.
Run Ro's free GLP-1 Insurance Coverage Checker →→ Still not sure which GLP-1 program is right for you?
Five questions, personalized action plan, no spam. We’ll match you to the path that fits your insurance, budget, medication preference, and state.
Take our free 60-second matching quiz →Sources & Verification
We verified every fact and number on this page against the following sources between April 25–28, 2026. We update this page quarterly and after any major pricing or policy change.
FDA MEDVi warning letter (February 20, 2026): FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
Ro pricing and Coverage Checker: ro.co/weight-loss/pricing; ro.co/weight-loss/glp1-insurance-checker
NovoCare Wegovy and Ozempic savings programs: novocare.com
LillyDirect Zepbound Self Pay Journey Program: zepbound.lilly.com/savings
IRS medical expense rules (HSA/FSA): IRS FAQ on medical expenses related to nutrition, wellness, and general health
CMS Medicare GLP-1 Bridge: cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
KFF Medicaid GLP-1 coverage (January 2026): kff.org
KFF / Peterson — employer GLP-1 coverage (2025): Peterson-KFF Health System Tracker
MEDVi Trustpilot: trustpilot.com/review/medvi.org
NABP Verify Before You Buy: nabp.pharmacy/resources/for-patients/verify-before-you-buy/
Last verified: . Next scheduled re-verification: July 28, 2026.
This page is editorial guidance produced by the Weight Loss Provider Guide editorial team — an independent comparison resource for GLP-1 telehealth providers. Our compensation comes from affiliate relationships with providers we cover, including MEDVi and Ro, but our segmentation, recommendations, and “wrong-fit” routing are not adjusted for payout. We don’t provide medical advice; for medical decisions, consult a licensed clinician.